Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit (Tables)

v3.19.1
Shareholders' Deficit (Tables)
 12 Months Ended
Dec. 31, 2018
Equity [Abstract]  
Schedule of nonvested activity
   

Number of

Non-vested Shares

     Weighted Average Grant Date Fair Value  
Nonvested, December 31, 2017     -     $ -  
Granted     6,483,732       0.62  
Forfeited     (485,060 )     0.85  
Nonvested, December 31, 2018     5,998,672     $ 0.61  
Schedule of stock option activities
    Number of Options     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term (Years)     Aggregate Intrinsic Value  
Balance Outstanding December 31, 2016     10,564,213     $ 0.42                  
Granted     4,330,000       0.29                  
Balance Outstanding December 31, 2017     14,894,213       0.32                  
Exercised     (1,757,032 )     0.12                  
Forfeited     (1,691,483 )     0.66                  
Balance Outstanding  December 31, 2018     11,445,698     $ 0.30       6.70     $ 3,291,240  
Exercisable, December 31, 2018     9,471,195     $ 0.28       6.28     $ 2,844,028  
Schedule of warrant activities
    Number of Warrants     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term (Years)     Aggregate Intrinsic Value  
Balance Outstanding December 31, 2017     -     $ -            -     $       -  
Granted     293,123       0.87                  
Cancelled     (293,123 )     (0.87 )                
Balance Outstanding  December 31, 2018     -     $ -       -     $ -  
Exercisable, December 31, 2018     -     $ -       -     $ -